{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:08:16Z","timestamp":1770822496224,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T00:00:00Z","timestamp":1212624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2342-8-11","type":"journal-article","created":{"date-parts":[[2008,6,6]],"date-time":"2008-06-06T06:13:31Z","timestamp":1212732811000},"source":"Crossref","is-referenced-by-count":42,"title":["Computer-assisted assessment of the Human Epidermal Growth Factor Receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls"],"prefix":"10.1186","volume":"8","author":[{"given":"Bonnie H","family":"Hall","sequence":"first","affiliation":[]},{"given":"Monica","family":"Ianosi-Irimie","sequence":"additional","affiliation":[]},{"given":"Parisa","family":"Javidian","sequence":"additional","affiliation":[]},{"given":"Wenjin","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Shridar","family":"Ganesan","sequence":"additional","affiliation":[]},{"given":"David J","family":"Foran","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,6,5]]},"reference":[{"issue":"4785","key":"51_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science. 1987, 235 (4785): 177-182. 10.1126\/science.3798106.","journal-title":"Science"},{"issue":"4758","key":"51_CR2","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1126\/science.3012781","volume":"232","author":"T Akiyama","year":"1986","unstructured":"Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T: The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science. 1986, 232 (4758): 1644-1646. 10.1126\/science.3012781.","journal-title":"Science"},{"issue":"6","key":"51_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/stem.160413","volume":"16","author":"JS Ross","year":"1998","unstructured":"Ross JS, Fletcher JA: The HER-2\/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells. 1998, 16 (6): 413-428.","journal-title":"Stem Cells"},{"issue":"20","key":"51_CR4","first-page":"4960","volume":"53","author":"MF Press","year":"1993","unstructured":"Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, et al: Her-2\/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res. 1993, 53 (20): 4960-4970.","journal-title":"Cancer Res"},{"issue":"5","key":"51_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/01.pap.0000213043.16200.92","volume":"13","author":"TY Leong","year":"2006","unstructured":"Leong TY, Leong AS: Controversies in the assessment of HER-2: more questions than answers. Adv Anat Pathol. 2006, 13 (5): 263-269. 10.1097\/01.pap.0000213043.16200.92.","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"51_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/2007-131-18-ASOCCO","volume":"131","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF: American Society of Clinical Oncology\/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. Arch Pathol Lab Med. 2007, 131 (1): 18-","journal-title":"Arch Pathol Lab Med"},{"issue":"21","key":"51_CR7","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2000.18.21.3651","volume":"18","author":"G Pauletti","year":"2000","unstructured":"Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R, Slamon DJ: Assessment of methods for tissue-based detection of the HER-2\/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol. 2000, 18 (21): 3651-3664.","journal-title":"J Clin Oncol"},{"issue":"4","key":"51_CR8","first-page":"929","volume":"25","author":"A Bankfalvi","year":"2004","unstructured":"Bankfalvi A, Boecker W, Reiner A: Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: a comparative methodological study using the Ventana BenchMark automated staining system and manual tests. Int J Oncol. 2004, 25 (4): 929-935.","journal-title":"Int J Oncol"},{"issue":"14","key":"51_CR9","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1200\/JCO.2002.09.094","volume":"20","author":"MF Press","year":"2002","unstructured":"Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L: Evaluation of HER-2\/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Oncol. 2002, 20 (14): 3095-3105.","journal-title":"J Clin Oncol"},{"issue":"1","key":"51_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF: American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007, 25 (1): 118-145. 10.1200\/JCO.2006.09.2775.","journal-title":"J Clin Oncol"},{"issue":"4","key":"51_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1309\/TMUW-G4WB-LXJ2-FUDN","volume":"116","author":"S Wang","year":"2001","unstructured":"Wang S, Saboorian MH, Frenkel EP, Haley BB, Siddiqui MT, Gokaslan S, Wians FH, Hynan L, Ashfaq R: Assessment of HER-2\/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol. 2001, 116 (4): 495-503. 10.1309\/TMUW-G4WB-LXJ2-FUDN.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"51_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2559.2005.02322.x","volume":"48","author":"OW Tawfik","year":"2006","unstructured":"Tawfik OW, Kimler BF, Davis M, Donahue JK, Persons DL, Fan F, Hagemeister S, Thomas P, Connor C, Jewell W, Fabian CJ: Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2\/neu expression in primary breast carcinoma. Histopathology. 2006, 48 (3): 258-267. 10.1111\/j.1365-2559.2005.02322.x.","journal-title":"Histopathology"},{"issue":"5","key":"51_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1309\/Y73U8X72B68TMGH5","volume":"121","author":"K Bloom","year":"2004","unstructured":"Bloom K, Harrington D: Enhanced accuracy and reliability of HER-2\/neu immunohistochemical scoring using digital microscopy. Am J Clin Pathol. 2004, 121 (5): 620-630. 10.1309\/Y73U-8X72-B68T-MGH5.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"51_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00129039-200403000-00001","volume":"12","author":"AS Leong","year":"2004","unstructured":"Leong AS: Quantitation in immunohistology: fact or fiction? A discussion of variables that influence results. Appl Immunohistochem Mol Morphol. 2004, 12 (1): 1-7.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"5","key":"51_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/cyto.a.20374","volume":"71","author":"AS Joshi","year":"2007","unstructured":"Joshi AS, Sharangpani GM, Porter K, Keyhani S, Morrison C, Basu AS, Gholap GA, Gholap AS, Barsky SH: Semi-automated imaging system to quantitate Her-2\/neu membrane receptor immunoreactivity in human breast cancer. Cytometry A. 2007, 71 (5): 273-285.","journal-title":"Cytometry A"},{"key":"51_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/jcp.2007.046763","volume":"61","author":"I Skaland","year":"2008","unstructured":"Skaland I, Ovestad I, Janssen EAM, Klos J, Kjellevold KH, Helliesen T, Baak JP: Comparing subjective and digital image analysis HER2\/neu expression scores with conventional and modified FISH scores in breast cancer. Journal of Clinical Pathology. 2008, 61: 68-71. 10.1136\/jcp.2007.046763.","journal-title":"Journal of Clinical Pathology"},{"issue":"9","key":"51_CR17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/00000478-200109000-00013","volume":"25","author":"T Seidal","year":"2001","unstructured":"Seidal T, Balaton AJ, Battifora H: Interpretation and quantification of immunostains. Am J Surg Pathol. 2001, 25 (9): 1204-1207. 10.1097\/00000478-200109000-00013.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"51_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1109\/TITB.2004.828891","volume":"8","author":"RM Chen W","year":"2004","unstructured":"Chen W RM, Foran DJ.: A prototype for unsupervised analysis of tissue microarrays for cancer research and diagnostics. IEEE Transactions on Information Technology in Biomedicine. 2004, 8 (2): 89-96. 10.1109\/TITB.2004.828891.","journal-title":"IEEE Transactions on Information Technology in Biomedicine"},{"key":"51_CR19","unstructured":"Ventana Scoring Guide. [ http:\/\/www.ventanamed.com\/products\/files\/ScoringGuide.pdf ]"},{"issue":"1","key":"51_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","volume":"9","author":"N Otsu","year":"1979","unstructured":"Otsu N: A threshold selection method from gray-level histograms. IEEE Trans Sys, Man, Cyber. 1979, 9 (1): 62-66.","journal-title":"IEEE Trans Sys, Man, Cyber"},{"issue":"1-2","key":"51_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11263-005-4635-4","volume":"62","author":"M Varma","year":"2005","unstructured":"Varma M, Zisserman A: A statistical approach to texture classification from single images. INT J COMPUT VISION. 2005, 62 (1-2): 61-81. 10.1007\/s11263-005-4635-4.","journal-title":"INT J COMPUT VISION"},{"key":"51_CR22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"DDM DeLong ER","year":"1988","unstructured":"DeLong ER DDM, Clarke-Pearson DL: Comparing the Area Under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach. Biometrics. 1988, 44: 837-845. 10.2307\/2531595.","journal-title":"Biometrics"},{"key":"51_CR23","unstructured":"VassarStats: Web Site for Statistical Computation. [ http:\/\/faculty.vassar.edu\/lowry\/VassarStats.html ]"},{"key":"51_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02295996","volume":"12","author":"Q McNemar","year":"1947","unstructured":"McNemar Q: Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947, 12: 153-157. 10.1007\/BF02295996.","journal-title":"Psychometrika"},{"issue":"10","key":"51_CR25","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1200\/JCO.2001.19.10.2587","volume":"19","author":"AD Seidman","year":"2001","unstructured":"Seidman AD, Fornier MN, Esteva FJ, Tan L, Kaptain S, Bach A, Panageas KS, Arroyo C, Valero V, Currie V, Gilewski T, Theodoulou M, Moynahan ME, Moasser M, Sklarin N, Dickler M, D'Andrea G, Cristofanilli M, Rivera E, Hortobagyi GN, Norton L, Hudis CA: Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol. 2001, 19 (10): 2587-2595.","journal-title":"J Clin Oncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2342-8-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2342-8-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2342-8-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2342-8-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T21:11:29Z","timestamp":1631394689000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/1471-2342-8-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1186\/1471-2342-8-11","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,5]]},"article-number":"11"}}